Search Medical Condition
Please enter condition
Please choose location
 

Ulaanbaatar, Mongolia Clinical Trials

A listing of Ulaanbaatar, Mongolia clinical trials actively recruiting patients volunteers.

RESULTS

Found (4) clinical trials

Liver Cancer Immunotherapy: Placebo-controlled Clinical Trial of Hepcortespenlisimut-L

Phase III, randomized, placebo-controlled, double-blinded trial aimed to seek the therapeutic benefit of hepcortespenlisimut-L (Hepko-V5) in subjects with advanced hepatocellular carcinoma. The results will be compared to placebo. The trial duration is 3 months and will consist of one stage with baseline laboratory evaluation including AFP levels with follow-up at ...

Phase

0.0 miles

Learn More »

Open Label Trial of Immunotherapy for Advanced Liver Cancer

Hepcortespenlisimut-L (V5) immunotherapy of HCC in an open label setting with baseline alphafetoprotein serum levels and CT scan image as primary endpoints with monthly follow-up thereafter. Additional endpoints will include blood biochemistry indices and safety monitoring.

Phase

0.0 miles

Learn More »

Open Label Immunotherapy Trial of Inoperable Pancreatic Cancer

This study is an open label Phase II study aimed to recruit at least 20 patients with inoperable PDA and who are positive for CA19.9 pancreatic tumor marker. The presence of higher than normal levels of CA19.9 is the sole inclusion criteria. Patients will be given one tablet of V3-P ...

Phase

0.0 miles

Learn More »

Vaccine Against Atherosclerosis in Patients With Overweight Problems or Obesity

The proposed study will evaluate daily dose of one V6 pill administered for one month in placebo-controlled, randomized, double-blind phase 3 trial in men and women with baseline waist diameter over 90 and 80 cm respectively. The effect of V6 will be assessed by changes in lipid profile, i.e., LDL, ...

Phase

2.69 miles

Learn More »